SARS-CoV-2 seroprevalence and antibody trajectories after easing of COVID-19 restrictions: a longitudinal study in China DOI Creative Commons
Ling Feng,

Zenghao Xu,

Jimin Sun

и другие.

Frontiers in Public Health, Год журнала: 2024, Номер 12

Опубликована: Дек. 3, 2024

We aimed to evaluate the seroprevalence of SARS-CoV-2 and investigate trajectories protective immunity associated risk factors in eastern China between March November 2023 after easing COVID-19 restrictions.

Язык: Английский

SARS-CoV-2 seroprevalence and antibody trajectories after easing of COVID-19 restrictions: a longitudinal study in China DOI Creative Commons
Ling Feng,

Zenghao Xu,

Jimin Sun

и другие.

Frontiers in Public Health, Год журнала: 2024, Номер 12

Опубликована: Дек. 3, 2024

We aimed to evaluate the seroprevalence of SARS-CoV-2 and investigate trajectories protective immunity associated risk factors in eastern China between March November 2023 after easing COVID-19 restrictions.

Язык: Английский

Процитировано

0